I'm thinking that Dr. J likely has a good number of options on CTIX shares, so he will benefit from continued CTIX Brilicidin prosperity, whether he remains here or not. My guess is that the heaviest part of lifting, at least his part, may already be done. After all, B for Abissi is well underway, as is B-OM, etc. There is more to do, BUT...

In the context of meeting the entrepreneurs and key staff of startup companies (in my role with an angel investing group) the greatest challenge and satisfaction one gets is from the early stages of development and of getting a company off the ground. They accrue the largest share of ownership of the new company at that point, something Dr. J could not do at CTIX.